Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

SOTRADECOL

SODIUM TETRADECYL SULFATE

Standard Dose
20MG/2ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SOTRADECOL is listed in Drugs@FDA under application 040541 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM TETRADECYL SULFATE Form and strength INJECTABLE;INJECTION - 20MG/2ML (10MG/ML) Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2019-05-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOTRADECOL is listed in Drugs@FDA under application 040541 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM TETRADECYL SULFATE Form and strength INJECTABLE;INJECTION - 20MG/2ML (10MG/ML) Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2019-05-22 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SOTRADECOL (SODIUM TETRADECYL SULFATE) | Drug Monograph | MedicHelpline